Retraction notice to "Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study": J Am Soc Hypertens 8 (2014) 422-428

  • J Am Soc Hypertens. 2015 Oct;9(10):822. doi: 10.1016/j.jash.2015.08.013.
Giuseppe Derosa  1 ,  Aldo Bonaventura  2 ,  Davide Romano  2 ,  Lucio Bianchi  2 ,  Elena Fogari  2 ,  Angela D'Angelo  2 ,  Pamela Maffioli  2
Affiliations
  • 1. Department of Internal Medicine and Therapeutics, University of Pavia and Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Center for the Study of Endocrine-Metabolic Pathophysiology and Clinical Research, University of Pavia, Pavia, Italy.
  • 2. Department of Internal Medicine and Therapeutics, University of Pavia and Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
PMID: 30153106 DOI: 10.1016/j.jash.2015.08.013
Products